Literature DB >> 24182604

Introduction to health economics and decision-making: Is economics relevant for the frontline clinician?

Ron Goeree1, Vakaramoko Diaby.   

Abstract

In a climate of escalating demands for new health care services and significant constraints on new resources, the disciplines of health economics and health technology assessment (HTA) have increasingly been turned to as explicit evidence-based frameworks to help make tough health care access and reimbursement decisions. Health economics is the discipline of economics concerned with the efficient allocation of health care resources, essentially trying to maximize health benefits to society contingent upon available resources. HTA is a broader field drawing upon several disciplines, but which relies heavily upon the tools of health economics and economic evaluation. Traditionally, health economics and economic evaluation have been widely used at the political (macro) and local (meso) decision-making levels, and have progressively had an important role even at informing individual clinical decisions (micro level). The aim of this paper is to introduce readers to health economics and discuss its relevance to frontline clinicians. Particularly, the content of the paper will facilitate clinicians' understanding of the link between economics and their medical practice, and how clinical decision-making reflects on health care resource allocation.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Keywords:  Clinical decision-making; Decision-making criteria; Economic evaluation; Health economics

Mesh:

Year:  2013        PMID: 24182604     DOI: 10.1016/j.bpg.2013.08.016

Source DB:  PubMed          Journal:  Best Pract Res Clin Gastroenterol        ISSN: 1521-6918            Impact factor:   3.043


  7 in total

1.  Survival modeling for the estimation of transition probabilities in model-based economic evaluations in the absence of individual patient data: a tutorial.

Authors:  Vakaramoko Diaby; Georges Adunlin; Alberto J Montero
Journal:  Pharmacoeconomics       Date:  2014-02       Impact factor: 4.981

Review 2.  Current challenges in health economic modeling of cancer therapies: a research inquiry.

Authors:  Jeffrey D Miller; Kathleen A Foley; Mason W Russell
Journal:  Am Health Drug Benefits       Date:  2014-05

Review 3.  The use of evaluation methods for the overall assessment of health policy: potential and limitations.

Authors:  Krzysztof Kaczmarek; Piotr Romaniuk
Journal:  Cost Eff Resour Alloc       Date:  2020-10-13

4.  Cost-effectiveness of B-type natriuretic peptide-guided care in patients with heart failure: a systematic review.

Authors:  Abdosaleh Jafari; Aziz Rezapour; Marjan Hajahmadi
Journal:  Heart Fail Rev       Date:  2018-09       Impact factor: 4.214

5.  Establishing activity centers for elderly people in metropolitan areas of Vietnam: preference and willingness-to-pay.

Authors:  Thu Thi Hoai Nguyen; Thanh Xuan Nguyen; Thang Pham; Cuong Tat Nguyen; Giang Thu Vu; Long Hoang Nguyen; Bach Xuan Tran; Huyen Thi Thanh Vu; Carl A Latkin; Cyrus Sh Ho; Roger Cm Ho
Journal:  J Multidiscip Healthc       Date:  2019-09-18

Review 6.  A review of methods to assess the economic impact of distributed medical education (DME) in Canada.

Authors:  Kim Lemky; Pierre Gagne; Jill Konkin; Karl Stobbe; Gervan Fearon; Sylvia Blom; Geneviève Maltais Lapointe
Journal:  Can Med Educ J       Date:  2018-03-27

7.  Telemedicine trends in orthopaedics and trauma during the COVID-19 pandemic: A bibliometric analysis and review.

Authors:  Arvind Kumar; Siddhartha Sinha; Javed Jameel; Sandeep Kumar
Journal:  J Taibah Univ Med Sci       Date:  2021-10-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.